Veeva Systems (NASDAQ:VEEV) was upgraded by investment analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm currently has a $40.00 price target on the stock. Morgan Stanley’s price target points to a potential upside of 61.75% from the company’s current price. The analysts noted that the move was a valuation call. Veeva Systems Inc (NYSE:VEEV) shares after opening at $24.78 moved to $25.10 on last trade day and at the end of the day closed at $23.10. Company price to sales ratio in past twelve months was calculated as 13.82 and price to cash ratio as 10.09. Veeva Systems Inc (NYSE:VEEV) showed a negative weekly performance of -14.16%.
Investors apparently took a break from heavy selling ofCastlight Health Inc (NYSE:CSLT) to allow it some energy upwards during trading Tuesday. The stock which undertook its initial public offering (IPO) just over two weeks ago has dropped almost 50 percent as concerns arise about it being overpriced. It is clearly hard to justify the pricing of the stock which although valued at close to $4 billion at the IPO, has known annual revenue of just about $13 million and losses running into $62.2 million in the previous year – 2013. Without company-specific new driving the stock upwards, it is clear investors are beginning to read or speculate about prospects in the cloud-based software business, a market that is growing very fast and in which Castlight Health Inc (NYSE:CSLT) thrives with its solutions which help businesses in achieving healthcare cost controls. It is important to keep a close eye here to see what happens with the stock in future. Castlight Health Inc (NYSE:CSLT) shares fell -4.30% in last trading session and ended the day on $21.57. CSLT return on equity ratio is recorded as 108.10% and its return on assets is -138.80%.
Analysts at Goldman Sachs initiated coverage on shares ofCoupons.Com (NASDAQ:COUP) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $21.00 price target on the stock. Goldman Sachs’ price target indicates a potential downside of 12.72% from the company’s current price. Coupons.Com Inc (NYSE:COUP) shares moved down -9.05% in last trading session and was closed at $20.60, while trading in range of $19.92-$23.13. Coupons.Com Inc (NYSE:COUP) year to date performance is -25.90%.
Care.com Inc (NYSE:CRCM) weekly performance is -15.58%. On last trading day company shares ended up $13.82. Care.com Inc (NYSE:CRCM) distance from 50-day simple moving average is -35.43%. Analysts mean target price for the company is $25.00.
Leave a Reply